|
LEO1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.048400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.631200E-04 |
| Normal-vs-Stage2 |
4.110600E-01 |
| Normal-vs-Stage3 |
5.070600E-01 |
| Normal-vs-Stage4 |
4.658600E-01 |
| Stage1-vs-Stage2 |
1.802420E-01 |
| Stage1-vs-Stage3 |
2.183300E-04 |
| Stage1-vs-Stage4 |
6.714200E-02 |
| Stage2-vs-Stage3 |
2.006200E-01 |
| Stage2-vs-Stage4 |
8.528800E-01 |
| Stage3-vs-Stage4 |
2.163000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.415700E-02 |
| Normal-vs-AfricanAmerican |
8.878200E-01 |
| Normal-vs-Asian |
4.983800E-01 |
| Caucasian-vs-AfricanAmerican |
2.411200E-01 |
| Caucasian-vs-Asian |
6.739400E-01 |
| AfricanAmerican-vs-Asian |
4.437200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.320800E-01 |
| Normal-vs-Female |
8.063700E-03 |
| Male-vs-Female |
5.681800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.432000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.799800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.482100E-02 |
| Normal-vs-Age(81-100Yrs) |
9.040000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.873600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.442600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.592200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.970600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.873400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.384800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.28589999999862E-05 |
| Normal-vs-Grade 2 |
1.438870E-03 |
| Normal-vs-Grade 3 |
3.407400E-01 |
| Normal-vs-Grade 4 |
2.317800E-01 |
| Grade 1-vs-Grade 2 |
3.603800E-02 |
| Grade 1-vs-Grade 3 |
5.738400E-03 |
| Grade 1-vs-Grade 4 |
2.036500E-04 |
| Grade 2-vs-Grade 3 |
2.119600E-02 |
| Grade 2-vs-Grade 4 |
2.158400E-04 |
| Grade 3-vs-Grade 4 |
5.731800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.34739999660505E-08 |
| Normal-vs-ccB subtype |
3.531500E-02 |
| ccA subtype-vs-ccB subtype |
6.66133814775094E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.534000E-01 |
| Normal-vs-N1 |
4.885600E-01 |
| N0-vs-N1 |
2.690800E-01 |
|
|
